{
    "eid": "2-s2.0-85128001667",
    "title": "Genetic variation in STAT4 is associated with treatment response to pegylated interferon in patients with chronic hepatitis B",
    "cover-date": "2022-03-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Immunology and Allergy",
            "@code": "2723",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Immunology",
            "@code": "2403",
            "@abbrev": "IMMU"
        }
    ],
    "keywords": [
        "Chronic hepatitis B",
        "pegylated interferon",
        "single nucleotide polymorphism",
        "STAT4",
        "virological response"
    ],
    "authors": [
        "Umaporn Limothai",
        "Natthaya Chuaypen",
        "Kittiyod Poovorawan",
        "Yong Poovorawan",
        "Pisit Tangkijvanich"
    ],
    "citedby-count": 0,
    "ref-count": 26,
    "ref-list": [
        "Chronic Hepatitis B Infection: A Review",
        "Management of hepatitis B: summary of a clinical research workshop",
        "Meta-analysis: Treatment of hepatitis B infection reduces risk of hepatocellular carcinoma",
        "Review article: genetic factors that modify the outcome of viral hepatitis",
        "Genetic variants in STAT4 and HLA-DQ genes confer risk of hepatitis B virus-related hepatocellular carcinoma",
        "Critical role for STAT4 activation by type 1 interferons in the interferon-gamma response to viral infection",
        "Genetic variations in STAT4,C2,HLA-DRB1 and HLA-DQ associated with risk of hepatitis B virus-related liver cirrhosis",
        "A STAT4 variant increases liver fibrosis risk in Caucasian patients with chronic hepatitis B",
        "Association of STAT4 polymorphisms with hepatitis B virus infection and clearance in Chinese Han population",
        "STAT4 genetic polymorphisms association with spontaneous clearance of hepatitis B virus infection",
        "Genetic variation in STAT4 predicts response to interferon-alpha therapy for hepatitis B e antigen-positive chronic hepatitis B",
        "EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection",
        "A case-control study on sequence variations in the enhancer II/core promoter/precore and X genes of hepatitis B virus in patients with hepatocellular carcinoma",
        "The Minor Allele of rs7574865 in the STAT4 Gene Is Associated with Increased mRNA and Protein Expression",
        "Non invasive evaluation of portal hypertension using transient elastography",
        "Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance",
        "Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C",
        "Effect of HLA-DP and IL28B gene polymorphisms on response to interferon treatment in hepatitis B e-antigen seropositive chronic hepatitis B patients",
        "A randomized clinical trial of peginterferon alpha-2b with or without entecavir in patients with HBeAg-negative chronic hepatitis B: Role of host and viral factors associated with treatment response",
        "Polymorphisms in STAT4, PTPN2, PSORS1C1 and TRAF3IP2 Genes Are Associated with the Response to TNF Inhibitors in Patients with Rheumatoid Arthritis",
        "STAT4 associates with systemic lupus erythematosus through two independent effects that correlate with gene expression and act additively with IRF5 to increase risk",
        "The STAT4 SLE risk allele rs7574865[T] is associated with increased IL-12-induced IFN-gamma production in T cells from patients with SLE",
        "Low pretreatment serum HBsAg level and viral mutations as predictors of response to PEG-interferon alpha-2b therapy in chronic hepatitis B",
        "On-treatment prediction of sustained response to peginterferon alfa-2a for HBeAg-negative chronic hepatitis B patients",
        "Baseline HBsAg and HBcrAg titres allow peginterferon-based \u2018precision medicine\u2019 in HBeAg-negative chronic hepatitis B patients",
        "A new role for an old marker, HBsAg"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60199573",
            "affilname": "Faculty of Tropical Medicine, Mahidol University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199573",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Center of Excellence in Clinical Virology",
        "Center of Excellence in Hepatitis and Liver Cancer",
        "Chulalongkorn Hospital",
        "Chulalongkorn University",
        "NSTDA",
        "Thailand Research Fund"
    ]
}